iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Windlas Biotech consolidated net profit declines 32.33% in the December 2021 quarter

2 Feb 2022 , 03:03 PM

Net profit of Windlas Biotech declined 32.33% to Rs 8.31 crore in the quarter ended December 2021 as against Rs 12.28 crore during the previous quarter ended December 2020. Sales rose 0.33% to Rs 117.59 crore in the quarter ended December 2021 as against Rs 117.20 crore during the previous quarter ended December 2020.

Particulars Quarter Ended
? Dec. 2021 Dec. 2020 % Var.
Sales 117.59 117.20 0
OPM % 11.10 14.83
PBDT 14.62 17.96 -19
PBT 11.48 14.62 -21
NP 8.31 12.28 -32

Powered by Capital Market – Live News

Related Tags

  • capital market
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.